Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial

Abstract

First randomized, controlled study, which evaluated treatment strategy after reaching low disease activity. One arm continues in full doses, second arm reduce doses and third withdrawer of etanercept.

Keywords

• rheumatoid arthritis
• etanercept
• DMARD